Fiscal Year 2007 - Department of Medicine - University of ...
Fiscal Year 2007 - Department of Medicine - University of ...
Fiscal Year 2007 - Department of Medicine - University of ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
70<br />
Sponsor and Title: HRSA, “The Delta Telehealth<br />
Partnership”<br />
Principal Investigator: Marshall J. Bouldin<br />
Project Period: 09/01/2005-08/31/<strong>2007</strong><br />
Annual Funding: $272,184<br />
Sponsor and Title: McKesson Health Solutions,<br />
“Cooperative Agreement for a Medicare Fee-For-<br />
Service Chronic Care Improvement”<br />
Principal Investigator: Marshall J. Bouldin<br />
Project Period: 05/05/2006-04/31/2008<br />
Annual Funding: $1,277,500<br />
Sponsor and Title: Mississippi State <strong>Department</strong><br />
<strong>of</strong> Health, “Diabetes Control Program”<br />
Principal Investigator: Marshall J. Bouldin<br />
Project Period: 01/01/2006-12/31/2006<br />
Annual Funding: $50,000<br />
Sponsor and Title: NorvoNordisk, “Sugar in the<br />
Delta: Culture and Disease”<br />
Principal Investigator: Marshall J. Bouldin<br />
Project Period: 04/06/2006-3/31/<strong>2007</strong><br />
Annual Funding: $30,000<br />
Sponsor and Title: AHRQ, “Addressing Preventable<br />
Medication Use Variance in Mississippi”<br />
Principal Investigator: C. Andrew Brown<br />
Project Period: 08/01/2001-09/01/2006<br />
Annual Funding: $142,557<br />
Sponsor and Title: AHRQ, “Detecting Medical<br />
Errors in Rural Hospitals Using Technology”<br />
Principal Investigator: C. Andrew Brown<br />
Project Period: 09/01/2004-8/31/<strong>2007</strong><br />
Annual Funding: $542,011<br />
Sponsor and Title: AHRQ, “Preventable Medication<br />
Use Variance in Mississippi (Minority Supplement)”<br />
Principal Investigator: C. Andrew Brown<br />
Project Period: 09/30/2001-09/30/2006<br />
Annual Funding: $76,280<br />
Sponsor and Title: Bristol-Myers Squibb, “Genital<br />
Ulcer Disease: A Risk Factor for Hepatitis C<br />
virus and Human Immunodeficiency Virus”<br />
Principal Investigator: Mary Jane Burton<br />
Project Period: 10/01/2005-09/30/2008<br />
Annual Funding: $15,000<br />
Sponsor and Title: Merck and Co., Inc., “Non<br />
ICU Surveillance Study: Incidence <strong>of</strong> Multiresistance<br />
in Serial Gram-Negative Isolates”<br />
Principal Investigator: Stanley W. Chapman<br />
Project Period: 07/1/2005-06/15/<strong>2007</strong><br />
Annual Funding: $7,000<br />
Sponsor and Title: HHS, “SWOG Clinical Research<br />
Associates Chair”<br />
Principal Investigator: Debbie Christie<br />
Project Period: 03/01/2006-02/28/<strong>2007</strong><br />
Annual Funding: $10,284<br />
Sponsor and Title: Research Mississippi Inc.<br />
“Cancer Clinical Trials”<br />
Principal Investigator: Minsig Choi<br />
Project Period: 02/01/<strong>2007</strong>-01/31/2008<br />
Annual Funding: $25, 000<br />
Sponsor and Title: Adventrx Pharmaceuticals,<br />
Inc., “A Phase III Multi-Center Randomized Clinical<br />
Trial to Evaluate the Safety and Efficacy <strong>of</strong><br />
CoFactor and 5-Fluorouracil (5-FU) plus Bevacizumab<br />
versus Leucovorin and 5-FU plus Bevacizumab<br />
as Initial Treatment for Metastatic<br />
Colorectal Carcinoma ”<br />
Principal Investigator: Minsig Choi<br />
Project Period: 04/03/<strong>2007</strong>-12/01/2009<br />
Annual Funding: $453,575<br />
Sponsor and Title: NIAID, “High Purity Amphotericin<br />
B: A Safer Antimycotic in AIDS”<br />
Principal Investigator: John Cleary<br />
Project Period: 04/01/2005-/03/31/<strong>2007</strong><br />
Annual Funding: $110,664